Beacon Hospital
Dublin D18 Ak68
1 studies enrolling now · 3 studies all time
What they study most
Carcinoma, Non-Small-Cell Lung, Heart Failure, Non-small Cell Lung Cancer
Studies at this site
- A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1% — Recruiting now
- Conduction System Pacing Optimized Therapy — Completed
- A Study of Tislelizumab (BGB-A317) Plus Chemoradiotherapy Followed by Tislelizumab Monotherapy in Newly Diagnosed, Stage III Subjects With Locally Advanced, Unresectable Non-small Cell Lung Cancer — Stopped early